A Clinical Study of 162 in Subjects With Chronic Hepatitis B Virus Infection

NCT06159062 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Enrollment difficulty

Conditions

Chronic Hepatitis B Virus Infection

Interventions

DRUG: 162
DRUG: Placebo

Sponsor

Yangshengtang Co., Ltd